On this page
SACS
sacsin molecular chaperone
The SACS gene provides instructions for producing sacsin, a protein thought to be involved in maintaining cellular structure and linked to inherited neurological conditions. The SACS gene encodes the sacsin protein, which is predominantly found in brain and muscle tissues.
SACS is located on the long (q) arm of chromosome 13, at band 13q12.12. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 13 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The SACS gene is responsible for creating the sacsin protein, which is expressed in various tissues including the brain, skin cells, and skeletal muscles. Although its specific functions are not fully understood, sacsin is implicated in critical cellular processes.
Disruptions in the SACS gene are primarily linked to inherited neurological disorders, most notably Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS). Understanding the SACS gene and its protein product is important for research into these conditions.
What the gene does
The sacsin protein, encoded by the SACS gene, is believed to play a role in maintaining the structural organisation of cells. Evidence suggests sacsin contributes to the assembly of intermediate filament structures, which form part of the cell's mechanical support system. These filament bundles are crucial for providing cellular strength and maintaining architectural integrity across different tissue types.
Neurons rely on neurofilaments - a type of intermediate filament - to determine axonal dimensions and morphology. Axons are critical for transmitting nerve impulses effectively between neurons and to muscle cells. Therefore, sacsin's involvement in neurofilament structure suggests a key role in neuronal health and function, though the exact mechanisms are still under investigation. The protein is found at low levels in the pancreas as well as higher levels in the brain and muscles.
Video: Genetics 101
Chromosome location
The SACS gene is located on chromosome 13, specifically at position 13q12.12. This chromosomal address indicates its precise position on the long arm (q) of chromosome 13. The gene's location helps in understanding its genetic neighbourhood and potential interactions with other genes in that region.
Protein structure
The sacsin protein, which consists of 4579 amino acids, features several distinct domains. These include a Ubiquitin-like domain spanning amino acids 9-84, a J domain from amino acids 4306-4393, and a HEPN domain located between amino acids 4451-4567. Additionally, the protein contains several disordered regions, specifically at amino acids 4248-4273, 4279-4298, and 4405-4427. These domains and disordered regions contribute to sacsin's overall structure and function.
Key variants
Genetic variations within the SACS gene can lead to changes in the sacsin protein, potentially impairing its normal function. These variants can include deletions, insertions, or single nucleotide changes. The impact of a specific variant depends on its location within the gene and how it alters the resulting protein. About 200 different mutations in the SACS gene have been found to cause Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS).
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.10222_10223del | p.Lys3408fs | Pathogenic/Likely pathogenic | ★★☆☆ | Charlevoix-Saguenay spastic ataxia |
c.12219del | p.Phe4073fs | Pathogenic | ★★☆☆ | Spastic paraplegia |
c.12890del | p.Lys4297fs | Pathogenic/Likely pathogenic | ★★☆☆ | Spastic paraplegia |
c.13236_13239del | p.Arg4412fs | Pathogenic/Likely pathogenic | ★★☆☆ | Spastic paraplegia |
c.4108C>T | p.Gln1370Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Charlevoix-Saguenay spastic ataxia |
c.6038del | p.Phe2012_Leu2013insTer | Pathogenic | ★★☆☆ | Charlevoix-Saguenay spastic ataxia |
c.6246del | p.Asn2082fs | Pathogenic | ★★☆☆ | Spastic paraplegia |
c.6312_6313del | p.His2105fs | Pathogenic/Likely pathogenic | ★★☆☆ | Charlevoix-Saguenay spastic ataxia |
c.6634_6637del | p.Thr2212fs | Pathogenic/Likely pathogenic | ★★☆☆ | Charlevoix-Saguenay spastic ataxia |
c.6965dup | p.Tyr2322Ter | Pathogenic/Likely pathogenic | ★★☆☆ | SACS-related disorder |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in the SACS gene are most commonly associated with Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS). This condition is an inherited neurological disorder characterised by a combination of muscle stiffness (spasticity) and problems with balance and coordination.
No condition pages are linked to this gene yet. This does not mean it has no associated conditions.
UK clinical status
The SACS gene is included in several Green-rated panels within the NHS Genomic Medicine Service's PanelApp, indicating strong evidence for its association with specific conditions and its utility in clinical genetic testing in the UK. These panels include 'Ataxia and cerebellar anomalies - childhood onset', 'Hereditary ataxia', 'Hereditary spastic paraplegia', and 'Mitochondrial disorders', among others. The gene is also part of the 'DDG2P' panel, which focuses on developmental disorders.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the main function of the SACS gene?
The SACS gene provides instructions for the sacsin protein, which is thought to play a role in organising intermediate filaments, essential structures that provide support and strength to cells, particularly in the brain and muscles.
What condition is most commonly associated with SACS gene variants?
Variants in the SACS gene are most commonly associated with Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS), a neurological disorder affecting muscle movement, balance, and coordination.
Where is the SACS gene located in the human genome?
The SACS gene is situated on chromosome 13, at the specific position 13q12.12, which is on the long arm of the chromosome.
References
- Gentil BJ, Lai GT, Menade M. Sacsin, mutated in the ataxia ARSACS, regulates intermediate filament assembly and dynamics. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2019. PMID: 30332300
- Takiyama Y. Sacsinopathies: sacsin-related ataxia. Cerebellum (London, England). 2007. PMID: 17853117
- Takiyama Y. Autosomal recessive spastic ataxia of Charlevoix-Saguenay. Neuropathology : official journal of the Japanese Society of Neuropathology. 2006. PMID: 16961075
- Mercier J, Prévost C, Engert JC. Rapid detection of the sacsin mutations causing autosomal recessive spastic ataxia of Charlevoix-Saguenay. Genetic testing. 2001. PMID: 11788093
- Engert JC, Bérubé P, Mercier J. ARSACS, a spastic ataxia common in northeastern Québec, is caused by mutations in a new gene encoding an 11.5-kb ORF. Nature genetics. 2000. PMID: 10655055